MiroBio

About:

MiroBio is Harnessing the natural control mechanisms of the immune system.

Top Investors: Oxford Science Enterprises, OrbiMed, SR One, Samsara BioCapital, Advent Life Sciences

Description:

MiroBio's platform is based on ground-breaking research by their scientific founders at the University of Oxford delineating how immune cells communicate and how they are activated. These insights have enabled MiroBio to create antibodies that can leverage natural signalling mechanisms to restore immune system balance and control.

Total Funding Amount:

107M GBP

Headquarters Location:

Oxford, Oxfordshire, United Kingdom

Founded Date:

2019-01-01

Contact Email:

info(AT)mirobio.com

Founders:

Richard Cornall, Simon Davis, Tim Funnell

Number of Employees:

11-50

Last Funding Date:

2022-06-29

IPO Status:

Private

Industries: